terazosin
- Product NDC
- 70518-3211
- 11-digit product format
- 705183211
- Labeler code
- 70518
- Product ID
- 70518-3211_ec560471-fd6b-47b8-e053-2a95a90ab2d4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- terazosin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA075614
- Marketing category
- ANDA
- Marketing start
- 2021-09-03
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-3211 | TERAZOSIN CAPSULE [REMEDYREPACK INC.] | 4 | Legacy NDC | 20240315_2af4a5ba-b919-4e93-86aa-09c3d4f8dd55.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3211-0 | 70518321100 | 30 CAPSULE in 1 BLISTER PACK (70518-3211-0) | 30 capsule | 2021-09-03 | 0000-00-00 | No | No | Current |